21-OHD CAH
21OHD diagnostic reports and evidence domains. The source matrix records whether findings address each domain.
Download CSV AtlasDomain-specific / Insufficient Evidence
Molecular confirmation
Insufficient Evidence
| Paper | Year | Study design | Reported sample size | Linked case records | Reported findings | Evidence source |
|---|---|---|---|---|---|---|
| Challenging Molecular Diagnosis of Congenital Adrenal Hyperplasia (CAH) Due to 21-Hydroxylase Deficiency: Case Series and Novel Variants of <i>CYP21A2</i> Gene. P001940 | 2024 | Case series; molecular diagnostic study | 3 | — | Molecular testing resolved complex CYP21A2 genotypes. The authors reported concordance with the severe phenotype in the study. | p. 2 source_checked |
Cite this page
Data version · v1.4.0